PMID- 27771242 OWN - NLM STAT- MEDLINE DCOM- 20170726 LR - 20220408 IS - 1873-1449 (Electronic) IS - 1538-4721 (Linking) VI - 16 IP - 1 DP - 2017 Jan-Feb TI - Incorporating three-dimensional ultrasound into permanent breast seed implant brachytherapy treatment planning. PG - 167-173 LID - S1538-4721(16)30551-7 [pii] LID - 10.1016/j.brachy.2016.09.007 [doi] AB - PURPOSE: Planning permanent breast seed implant (PBSI) brachytherapy using CT alone may reduce treatment accuracy because of differences in seroma visualization compared with ultrasound (US). This study evaluates dosimetric effects of seroma delineation in PBSI and the potential impact of incorporating three-dimensional (3D) US into PBSI treatment planning. METHODS AND MATERIALS: Spatially coregistered CT and 3D US images from 10 patients were retrospectively analyzed to simulate the PBSI procedure. Seromas contoured on CT and US defined clinical target volumes, CTV(CT) and CTV(US), which were expanded to create planning target volumes (PTVs). PBSI plans were generated using PTV(CT) alone, and the resulting coverage to PTV(US) was evaluated. To assess the potential impact of transferring to an US-guided procedure, the CT-based plans were centered on CTV(US). The volume encompassed by both PTVs was used to evaluate how 3D US can affect the planning procedure. RESULTS: Median (range) PTV(CT)V(100) was 95.6% (93.3-97.3%), resulting in PTV(US) coverage of 91.5% (80.5-97.9%). Centering plans on CTV(US) decreased PTV(CT)V(100) by a mean of 10 +/- 8%, and increased PTV(US)V(100) by 5 +/- 4%. The combined PTVs were a mean 9+/-6% larger than PTV(CT). Acceptable dosimetry to the combined PTVs resulted in sufficient coverage to individual PTVs but with a mean 11 +/- 24% increase to skin dose and 6 +/- 8% increase in breast V(200). CONCLUSIONS: Differences in seroma visualization have dosimetric effects in PBSI. CT-based plans can underdose US-defined volumes and may not adequately translate to an US-guided procedure. Implementing 3D US into planning can potentially compensate for differences in delineation. CI - Copyright (c) 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved. FAU - Morton, Daniel AU - Morton D AD - Department of Medical Physics, BC Cancer Agency, Centre for the Southern Interior, Kelowna, British Columbia, Canada; Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada. Electronic address: dmorton@bccancer.bc.ca. FAU - Batchelar, Deidre AU - Batchelar D AD - Department of Medical Physics, BC Cancer Agency, Centre for the Southern Interior, Kelowna, British Columbia, Canada. FAU - Hilts, Michelle AU - Hilts M AD - Department of Medical Physics, BC Cancer Agency, Centre for the Southern Interior, Kelowna, British Columbia, Canada; Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada. FAU - Berrang, Tanya AU - Berrang T AD - Department of Radiation Oncology, BC Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada. FAU - Crook, Juanita AU - Crook J AD - Department of Radiation Oncology, BC Cancer Agency, Centre for the Southern Interior, Kelowna, British Columbia, Canada. LA - eng PT - Journal Article DEP - 20161019 PL - United States TA - Brachytherapy JT - Brachytherapy JID - 101137600 SB - IM MH - Brachytherapy/*methods MH - Breast Neoplasms/diagnostic imaging/*radiotherapy MH - Female MH - Humans MH - Imaging, Three-Dimensional MH - Postoperative Complications/*diagnostic imaging MH - Radiometry MH - Radiotherapy Dosage MH - Radiotherapy Planning, Computer-Assisted/*methods MH - Radiotherapy, Adjuvant MH - Retrospective Studies MH - Seroma/*diagnostic imaging MH - *Tomography, X-Ray Computed MH - *Ultrasonography OTO - NOTNLM OT - 3D ultrasound OT - Accelerated partial breast irradiation OT - Breast brachytherapy OT - Permanent breast seed implants OT - Seroma OT - Treatment planning EDAT- 2016/10/25 06:00 MHDA- 2017/07/27 06:00 CRDT- 2016/10/25 06:00 PHST- 2016/07/12 00:00 [received] PHST- 2016/09/12 00:00 [revised] PHST- 2016/09/13 00:00 [accepted] PHST- 2016/10/25 06:00 [pubmed] PHST- 2017/07/27 06:00 [medline] PHST- 2016/10/25 06:00 [entrez] AID - S1538-4721(16)30551-7 [pii] AID - 10.1016/j.brachy.2016.09.007 [doi] PST - ppublish SO - Brachytherapy. 2017 Jan-Feb;16(1):167-173. doi: 10.1016/j.brachy.2016.09.007. Epub 2016 Oct 19.